Endocrinology2

Others

2022年9月11日(日) 08:00 〜 20:00 現地会場なし (配信のみ)

+全てマイスケジュールに登録

[WP-5-1] Secondary primary malignancies in thyroid cancer survivors treated by radioiodine I-131. Is it really linked with radioiodine therapy? an experience in a single center

Kunihiro Nakada¹、Arinori Yoshida²、Hiroki Sugie²、Yasushi Furuta³、Masayuki Sakurai¹ (1.Hokko Memorial Hospial、2.LSI Sapporo Clinic、3.Teine Keijinkai Hospital)

[WP-5-2] Relationship between salivary gland damages and cumulative activity of I-131 in patties undergoing high-dose radio iodine therapy for thyroid cancer.

Kunihiro Nakada¹、Kazuyuki Minowa²、Sigeru Yamano²、Masayuki Sakurai²、Yasushi Furuta³ (1.Hokko Meorial Hispial、2.Hokkaido University Hospital、3.Teine Keijinkai Hospital)

[WP-5-3] Comparison between 11C-methionine PET/CT and 99mTc-MIBI SPECT/CT for localization of parathyroid adenomas/ hyperplasia: third level medical center experience.

Isaac Gonzalez、Eleazar Ignacio (Instituto Nacional De Ciencias Médicas Y Nutrición Salvador Zubirán)

[WP-5-4] A case of brown tumor associated with parathyroid carcinoma

Hitomi Kawamura、Kazuna Kawabata、Makoto Hosono、Mitsunori Kanagaki、Saya Ando、Shin Morooka、Masaki Umehana、Shuichi Ito、Kuniaki Takata、Hiroyuki Kimura (Hyogo Prefectural Amagasaki General Medical Center)

[WP-5-5] Physiological adrenal FDG uptake higher than the liver is not rare in PET/CT studies using SiPM-based scanner.

Akira Toriihara¹、Katsuya Yoshida¹、Hirofumi Yamada²、Sho Watanabe²、Jun Isogai² (1.PET Imaging Center, Asahi General Hospital、2.Department of Radiology, Asahi General Hospital)